MoldCo

The health platform for the modern environment

Cambridge, United States · Founded 2023 · $8.0M raised

Headquarters
Cambridge, Texas
Employees
11–50
Founded
2023
Business Model
B2C
Website
moldco.com
Total Funding
$8.0M
Last Round
$8.0M SeedOct 2025
Rounds
1

About

MoldCo is a clinician-led virtual healthcare platform that provides mold toxicity testing, diagnosis, and evidence-based treatment protocols for patients suffering from mold and environmental toxin exposure. The company offers a comprehensive membership model combining at-home lab testing, telehealth consultations, and personalized treatment protocols guided by providers trained in Dr. Shoemaker's biotoxin illness methodology. With 95% of patients reporting symptom improvement within the first 30 days and an average 64% reduction in total symptoms within 120 days, MoldCo is expanding nationwide to address an estimated 50 million Americans living with undiagnosed mold-related illness.

Summary

MoldCo is a Healthcare company based in Cambridge, United States, founded in 2023. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Oct 2025. Investors include Cantos and Collaborative Fund.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundOct 2025
$8.0M

Investors

Similar Companies